查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1522714

全球生物樣本庫市場評估:按產品和服務,樣本類型,存儲類型,所有者,應用,最終用戶,地區,機會,預測2017-2031年

Biobanking Market Assessment, By Product and Service, By Sample Type, By Storage Type, By Ownership, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 235 Pages | 商品交期: 3-5個工作天內

價格

全球生物樣本庫市場規模預計將從 2023 年的 706.9 億美元成長到 2031 年的 1,270.2 億美元，在 2024 年至 2031 年的預測期內複合年增長率為 7.60%。市場成長的推動因素包括人們對生物樣本庫各種益處的認識不斷提高、慢性病病例的增加以及生物樣本庫投資的增加。

對精準醫療和基因檢測的日益重視，以及新生兒臍帶血幹細胞保存的日益普及，也推動了市場的成長。這種增長是由於人們越來越認識到從臍帶血中採集的幹細胞帶來的各種好處。這些幹細胞可用於增強接受癌症治療的患者的免疫系統，並可冷凍保存以供將來應用。

多種慢性病和殘疾發生率的上升是全球生物樣本庫市場的主要趨勢之一。借助基於人群的生物樣本庫，研究人員可以結合實驗室檢測結果、臨床數據、影像數據、問卷數據和分子數據來研究各種疾病發生過程中外部因素的暴露以及個體遺傳易感性的作用。此外，生物樣本庫提供的生物樣本可用於驗證和篩選潛在的生物標記。例如，透過分析癌症患者的腫瘤樣本，研究人員可以發現與腫瘤發展相關的蛋白質表現模式的變化和基因突變。

該報告考察了全球生物樣本庫市場，並按產品和服務、樣本類型、儲存類型、所有者、應用程式、最終用戶、地區、地區趨勢和市場參與者提供了市場概述 提供公司簡介等。

目錄

第1章 研究方法論

第2章 專案範圍與定義

第3章 執行摘要

第4章 2017-2031 年全球生物樣本庫市場前景

  • 市場規模及預測
  • 按產品/服務
  • 依樣品類型
  • 依儲存類型
  • 由業主
  • 按用途
  • 按最終用戶
  • 按地區
  • 按公司劃分的市佔率 (%)，2023 年

第5章 2017-2031 年全球生物樣本庫市場展望（按地區）

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第6章 市場測繪，2023 年

第7章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第8章 市場動態

第9章 監理架構與創新

第10章 主要與企業狀況

第11章 價格分析

第12章 案例研究

第13章 主要進入者展望

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Merck & Co., Inc.
  • Hamilton Company
  • Tecan Group Ltd.
  • Azenta US, Inc.
  • BioLife Solutions Inc.
  • VWR International, LLC
  • Biovault Technical

第14章 戰略建議

第15章 查詢及免責聲明

Product Code: MX11664

Global biobanking market is projected to witness a CAGR of 7.60% during the forecast period 2024-2031, growing from USD 70.69 billion in 2023 to USD 127.02 billion in 2031. The growth of the market is augmented by the growing awareness of various advantages associated with biobanks, rise in cases of chronic diseases, and increasing investments towards biobanks.

The increasing emphasis on precision medicine and genetic testing and the rising popularity of cord blood stem cell preservation in newborns boosts the market's growth. This rise can be attributed to the growing awareness about the various advantages associated with stem cells from cord blood. These stem cells can be used to strengthen the immune system of patients undergoing cancer treatments and can be frozen and stored away for future applications.

The rising incidences of several chronic diseases and disorders are one of the significant global biobanking market trends. With the help of population-based biobanks, researchers are able to examine the role of exposure to external factors and individual genetic susceptibility in the development of various diseases by combining laboratory test results, clinical data, imaging data, and questionnaire data with molecular data. Additionally, the biological samples provided by biobanks can aid in validating and screening potential biomarkers. For instance, by analyzing tumor samples from cancer patients, researchers are able to discover changes in protein expression patterns and gene mutations that are associated with tumor development.

Increasing Prevalence of Chronic Diseases Boosts Market Demand

The rise in the number of cases of various chronic diseases in different regions is propelling the global biobanking market demand. Cardiovascular disorders are one of the leading causes of death. Cardiology research has discovered several genetic markers and proteins that might be responsible for the disorders. Biobanks have played a crucial role in these research activities by providing relevant samples to enhance the understanding of the therapy, prognosis, and diagnosis of cardiovascular disorders. According to the estimates of the US Centers for Disease Control and Prevention, approximately 695,000 individuals died from heart disease in 2021.

Similarly, cancer cases are rising, propelling the market demand as biobanks store samples and other essential data in a planned and systematic manner. This allows for detection, diagnosis, treatment, prevention of cancer, progressing genetic studies, and aiding researchers in identifying potential drug targets. The American Cancer Society estimated that 2,001,140 new cases of cancer and 611,720 deaths related to the disease are expected to occur in 2024 in the United States.

Rising Investments Towards Biobanks Support Market Expansion

The increasing investments in biobanks due to the growing awareness of various advantages is one of the significant factors bolstering the global biobanking market growth. Biobanks play a crucial role in precision medicine and have supported medical advancements, such as anticipation of dementia, similar conditions, and prevention of heart attacks. Biobanking technology has aided healthcare professionals and researchers in developing tests capable of predicting patients' response to immunotherapy. Furthermore, the DNA data collected from biobanks has allowed researchers to determine the correct dosages of anticoagulants, thus boosting investments in biobanks in various regions across the globe. In June 2024, the iCAN national program launched a funding of USD 2.7 million (EUR 2.5 million) for cancer centers biobank projects. The project is expected to expand the molecular profiling of cancer in Finland and aims to identify new targets for treatment. The project, launched within the framework of the Southern Cancer Center and in cooperation between the HUS Helsinki University Hospital and the University of Helsinki, aims to expand to all the FICAN National Cancer Centers in alliance with the regional biobanks.

Europe Expected to Account for Significant Market Share

The growth of the European market is augmented by the strong presence of key market players, expansion of the research and development sector in healthcare, and growing awareness about various advantages associated with biobanks. Biobanking is essential for preserving specimens and plays a crucial role in enhancing the knowledge of healthcare professionals and researchers, allowing them to develop new technologies for treating and detecting diseases. Thus, the market is witnessing significant growth in Europe due to the rising prevalence of various chronic diseases in the region. According to the estimates of the Europa Donna, The European Breast Cancer Coalition, 604,900 incidences of cancer were reported in Europe in 2022. This increase is further propelling the requirement for biobanks in the region as they play a vital role in aiding researchers in studying various mechanisms associated with the development of cancer and their response to treatment, progression, and resistance.

Equipment Segment Anticipated to Hold Significant Market Share

The expansion of the segment is supported by the rising collection of bio-samples and an increasing number of biobanks. Biobanking equipment plays a crucial role in storing, processing, analyzing, and transporting samples and is responsible for catering to the diverse sets of requirements of medical facilities, biobanks, and research institutes. The rising efforts of various medical technology companies towards the development and introduction of advanced solutions is another major factor supporting the segment's expansion. In July 2023, Tecan Group Ltd. introduced a new phase separator to enhance automation in biobanking and liquid biopsy. The phase separator is expected to support advancements across various disease areas, including metabolic diseases, neurodegenerative diseases, oncology, proteomics, genomics, and others.

Future Market Scenario (2024 - 2031F)

The increasing investments in constructing biobanks are expected to boost the market's growth in the forecast years. Various clinical trials for several diseases and increasing utilization of stem cell therapies for treating rare and chronic diseases are other significant factors expected to boost the requirement for biobanking products. The increasing complexity of life science research is another major factor creating the requirement for high-quality specimens, which in turn is augmenting the investments in the construction of biobanks. Additionally, advancements in biomedical research technologies, such as molecular profiling, high-throughput screening, and next-generation sequencing, are propelling the requirement for large-scale sample repositories to support their execution. Thus, due to the rising efforts of researchers to enhance human health and increase their understanding of various diseases, the requirement for biobanking is expected to rise in the coming years.

Key Players Landscape and Outlook

The rising investments by the key players of the market toward the introduction of novel technologies are bolstering the global biobanking market size. In January 2024, Thermo Fisher Scientific Inc. announced the launch of the new Axiom PangenomiX Array, their ethnically diverse and most extensive array that offers genetic coverage in pharmacogenomic research and population-scale disease research studies. At present, the array is the only research solution that combines fixed copy number discovery, whole-genome copy number variant detection, HLA typing, and SNP genotyping in one test. The array has already found application at a leading biobank in the United States for analyzing close to half a million ethnically diverse samples.

Additionally, in May 2024, Hamilton Company announced that four high-capacity BiOS automated storage systems will be installed in the new Manchester Science Park headquarters of the United Kingdom Biobank. The systems are expected to store over 12 million biological samples and have a capacity of an additional 8 million samples.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Biobanking Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product and Service
    • 4.2.1. Equipment
      • 4.2.1.1. Storage Equipment
      • 4.2.1.2. Sample Processing Equipment
      • 4.2.1.3. Sample Analysis Equipment
      • 4.2.1.4. Sample Transport Equipment
    • 4.2.2. Consumables
      • 4.2.2.1. Storage Consumables
      • 4.2.2.2. Processing Consumables
      • 4.2.2.3. Analysis Consumables
      • 4.2.2.4. Collection Consumables
    • 4.2.3. Services
      • 4.2.3.1. Storage Services
      • 4.2.3.2. Processing Services
      • 4.2.3.3. Transport Services
      • 4.2.3.4. Supply Services
    • 4.2.4. Software
  • 4.3. By Sample Type
    • 4.3.1. Stem Cells
    • 4.3.2. Human Tissues
    • 4.3.3. Blood Product
    • 4.3.4. Biological Fluids
    • 4.3.5. Human Waste Products
    • 4.3.6. Nucleic Acids
  • 4.4. By Storage Type
    • 4.4.1. Manual Storage
    • 4.4.2. Automated Storage
  • 4.5. By Ownership
    • 4.5.1. National/Regional Agencies
    • 4.5.2. Universities
    • 4.5.3. Private Organizations
    • 4.5.4. Non-profit Organizations
  • 4.6. By Application
    • 4.6.1. Life Science Research
    • 4.6.2. Clinical Research
    • 4.6.3. Regenerative Medicine
  • 4.7. By End-user
    • 4.7.1. Pharmaceutical and Biotechnology Companies
    • 4.7.2. CROs and CMOs
    • 4.7.3. Academic and Research Institutes
    • 4.7.4. Hospitals
  • 4.8. By Region
    • 4.8.1. North America
    • 4.8.2. South America
    • 4.8.3. Europe
    • 4.8.4. Asia-Pacific
    • 4.8.5. Middle East & Africa
  • 4.9. By Company Market Share (%), 2023

5. Global Biobanking Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product and Service
      • 5.1.2.1. Equipment
        • 5.1.2.1.1. Storage Equipment
        • 5.1.2.1.2. Sample Processing Equipment
        • 5.1.2.1.3. Sample Analysis Equipment
        • 5.1.2.1.4. Sample Transport Equipment
      • 5.1.2.2. Consumables
        • 5.1.2.2.1. Storage Consumables
        • 5.1.2.2.2. Processing Consumables
        • 5.1.2.2.3. Analysis Consumables
        • 5.1.2.2.4. Collection Consumables
      • 5.1.2.3. Services
        • 5.1.2.3.1. Storage Services
        • 5.1.2.3.2. Processing Services
        • 5.1.2.3.3. Transport Services
        • 5.1.2.3.4. Supply Services
      • 5.1.2.4. Software
    • 5.1.3. By Sample Type
      • 5.1.3.1. Stem Cells
      • 5.1.3.2. Human Tissues
      • 5.1.3.3. Blood Product
      • 5.1.3.4. Biological Fluids
      • 5.1.3.5. Human Waste Products
      • 5.1.3.6. Nucleic Acids
    • 5.1.4. By Storage Type
      • 5.1.4.1. Manual Storage
      • 5.1.4.2. Automated Storage
    • 5.1.5. By Ownership
      • 5.1.5.1. National/Regional Agencies
      • 5.1.5.2. Universities
      • 5.1.5.3. Private Organizations
      • 5.1.5.4. Non-profit Organizations
    • 5.1.6. By Application
      • 5.1.6.1. Life Science Research
      • 5.1.6.2. Clinical Research
      • 5.1.6.3. Regenerative Medicine
    • 5.1.7. By End-user
      • 5.1.7.1. Pharmaceutical and Biotechnology Companies
      • 5.1.7.2. CROs and CMOs
      • 5.1.7.3. Academic and Research Institutes
      • 5.1.7.4. Hospitals
    • 5.1.8. United States*
      • 5.1.8.1. Market Size & Forecast
        • 5.1.8.1.1. By Value
        • 5.1.8.1.2. By Volume
      • 5.1.8.2. By Product and Service
        • 5.1.8.2.1. Equipment
          • 5.1.8.2.1.1. Storage Equipment
          • 5.1.8.2.1.2. Sample Processing Equipment
          • 5.1.8.2.1.3. Sample Analysis Equipment
          • 5.1.8.2.1.4. Sample Transport Equipment
        • 5.1.8.2.2. Consumables
          • 5.1.8.2.2.1. Storage Consumables
          • 5.1.8.2.2.2. Processing Consumables
          • 5.1.8.2.2.3. Analysis Consumables
          • 5.1.8.2.2.4. Collection Consumables
        • 5.1.8.2.3. Services
          • 5.1.8.2.3.1. Storage Services
          • 5.1.8.2.3.2. Processing Services
          • 5.1.8.2.3.3. Transport Services
          • 5.1.8.2.3.4. Supply Services
        • 5.1.8.2.4. Software
      • 5.1.8.3. By Sample Type
        • 5.1.8.3.1. Stem Cells
        • 5.1.8.3.2. Human Tissues
        • 5.1.8.3.3. Blood Product
        • 5.1.8.3.4. Biological Fluids
        • 5.1.8.3.5. Human Waste Products
        • 5.1.8.3.6. Nucleic Acids
      • 5.1.8.4. By Storage Type
        • 5.1.8.4.1. Manual Storage
        • 5.1.8.4.2. Automated Storage
      • 5.1.8.5. By Ownership
        • 5.1.8.5.1. National/Regional Agencies
        • 5.1.8.5.2. Universities
        • 5.1.8.5.3. Private Organizations
        • 5.1.8.5.4. Non-profit Organizations
      • 5.1.8.6. By Application
        • 5.1.8.6.1. Life Science Research
        • 5.1.8.6.2. Clinical Research
        • 5.1.8.6.3. Regenerative Medicine
      • 5.1.8.7. By End-user
        • 5.1.8.7.1. Pharmaceutical and Biotechnology Companies
        • 5.1.8.7.2. CROs and CMOs
        • 5.1.8.7.3. Academic and Research Institutes
        • 5.1.8.7.4. Hospitals
    • 5.1.9. Canada
    • 5.1.10. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product and Service
  • 6.2. By Sample Type
  • 6.3. By Storage Type
  • 6.4. By Ownership
  • 6.5. By Application
  • 6.6. By End-user
  • 6.7. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Danaher Corporation
  • 13.3. Becton, Dickinson and Company
  • 13.4. Merck & Co., Inc.
  • 13.5. Hamilton Company
  • 13.6. Tecan Group Ltd.
  • 13.7. Azenta US, Inc.
  • 13.8. BioLife Solutions Inc.
  • 13.9. VWR International, LLC
  • 13.10. Biovault Technical

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 4. Global Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 5. Global Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 6. Global Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 7. Global Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 8. Global Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 9. Global Biobanking Market Share (%), By Region, 2017-2031F
  • Figure 10. North America Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 11. North America Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 12. North America Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 13. North America Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 14. North America Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 15. North America Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 16. North America Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 17. North America Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 18. North America Biobanking Market Share (%), By Country, 2017-2031F
  • Figure 19. United States Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 20. United States Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 21. United States Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 22. United States Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 23. United States Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 24. United States Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 25. United States Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 26. United States Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 27. Canada Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Canada Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 29. Canada Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 30. Canada Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 31. Canada Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 32. Canada Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 33. Canada Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 34. Canada Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 35. Mexico Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 36. Mexico Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 37. Mexico Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 38. Mexico Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 39. Mexico Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 40. Mexico Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 41. Mexico Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 42. Mexico Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 43. Europe Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 44. Europe Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 45. Europe Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 46. Europe Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 47. Europe Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 48. Europe Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 49. Europe Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 50. Europe Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 51. Europe Biobanking Market Share (%), By Country, 2017-2031F
  • Figure 52. Germany Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Germany Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 54. Germany Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 55. Germany Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 56. Germany Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 57. Germany Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 58. Germany Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 59. Germany Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 60. France Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. France Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 62. France Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 63. France Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 64. France Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 65. France Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 66. France Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 67. France Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 68. Italy Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 69. Italy Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 70. Italy Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 71. Italy Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 72. Italy Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 73. Italy Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 74. Italy Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 75. Italy Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 76. United Kingdom Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. United Kingdom Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 78. United Kingdom Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 79. United Kingdom Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 80. United Kingdom Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 81. United Kingdom Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 82. United Kingdom Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 83. United Kingdom Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 84. Russia Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 85. Russia Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 86. Russia Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 87. Russia Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 88. Russia Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 89. Russia Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 90. Russia Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 91.
  • Figure 92. Russia Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 93. Netherlands Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 94. Netherlands Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 95. Netherlands Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 96. Netherlands Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 97. Netherlands Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 98. Netherlands Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 99. Netherlands Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 100. Netherlands Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 101. Spain Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Spain Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 103. Spain Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 104. Spain Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 105. Spain Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 106. Spain Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 107. Spain Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 108. Spain Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 109. Turkey Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. Turkey Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 111. Turkey Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 112. Turkey Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 113. Turkey Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 114. Turkey Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 115. Turkey Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 116. Turkey Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 117. Poland Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Poland Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 119. Poland Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 120. Poland Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 121. Poland Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 122. Poland Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 123. Poland Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 124. Poland Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 125. South America Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 126. South America Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 127. South America Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 128. South America Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 129. South America Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 130. South America Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 131. South America Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 132. South America Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 133. South America Biobanking Market Share (%), By Country, 2017-2031F
  • Figure 134. Brazil Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 135. Brazil Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 136. Brazil Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 137. Brazil Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 138. Brazil Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 139. Brazil Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 140. Brazil Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 141. Brazil Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 142. Argentina Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 143. Argentina Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 144. Argentina Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 145. Argentina Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 146. Argentina Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 147. Argentina Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 148. Argentina Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 149. Argentina Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 150. Asia-Pacific Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. Asia-Pacific Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 152. Asia-Pacific Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 153. Asia-Pacific Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 154. Asia-Pacific Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 155. Asia-Pacific Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 156. Asia-Pacific Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 157. Asia-Pacific Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 158. Asia-Pacific Biobanking Market Share (%), By Country, 2017-2031F
  • Figure 159. India Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 160. India Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 161. India Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 162. India Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 163. India Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 164. India Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 165. India Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 166. India Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 167. China Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. China Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 169. China Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 170. China Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 171. China Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 172. China Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 173. China Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 174. China Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 175. Japan Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Japan Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 177. Japan Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 178. Japan Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 179. Japan Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 180. Japan Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 181. Japan Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 182. Japan Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 183. Australia Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 184. Australia Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 185. Australia Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 186. Australia Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 187. Australia Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 188. Australia Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 189. Australia Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 190. Australia Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 191. Vietnam Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 192. Vietnam Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 193. Vietnam Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 194. Vietnam Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 195. Vietnam Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 196. Vietnam Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 197. Vietnam Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 198. Vietnam Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 199. South Korea Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 200. South Korea Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 201. South Korea Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 202. South Korea Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 203. South Korea Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 204. South Korea Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 205. South Korea Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 206. South Korea Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 207. Indonesia Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 208. Indonesia Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 209. Indonesia Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 210. Indonesia Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 211. Indonesia Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 212. Indonesia Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 213. Indonesia Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 214. Indonesia Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 215. Philippines Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 216. Philippines Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 217. Philippines Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 218. Philippines Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 219. Philippines Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 220. Philippines Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 221. Philippines Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 222. Philippines Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 223. Middle East & Africa Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 224. Middle East & Africa Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 225. Middle East & Africa Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 226. Middle East & Africa Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 227. Middle East & Africa Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 228. Middle East & Africa Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 229. Middle East & Africa Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 230. Middle East & Africa Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 231. Middle East & Africa Biobanking Market Share (%), By Country, 2017-2031F
  • Figure 232. Saudi Arabia Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 233. Saudi Arabia Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 234. Saudi Arabia Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 235. Saudi Arabia Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 236. Saudi Arabia Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 237. Saudi Arabia Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 238. Saudi Arabia Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 239. Saudi Arabia Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 240. UAE Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 241. UAE Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 242. UAE Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 243. UAE Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 244. UAE Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 245. UAE Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 246. UAE Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 247. UAE Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 248. South Africa Biobanking Market, By Value, In USD Billion, 2017-2031F
  • Figure 249. South Africa Biobanking Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 250. South Africa Biobanking Market Share (%), By Product and Service, 2017-2031F
  • Figure 251. South Africa Biobanking Market Share (%), By Sample Type, 2017-2031F
  • Figure 252. South Africa Biobanking Market Share (%), By Storage Type, 2017-2031F
  • Figure 253. South Africa Biobanking Market Share (%), By Ownership, 2017-2031F
  • Figure 254. South Africa Biobanking Market Share (%), By Application, 2017-2031F
  • Figure 255. South Africa Biobanking Market Share (%), By End-user, 2017-2031F
  • Figure 256. By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 257. By Sample Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 258. By Storage Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 259. By Ownership Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 260. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 261. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 262. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023